Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-01
1998-12-15
Uem, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 530350, 530399, A61K 3818, A61K 3830
Patent
active
058496874
ABSTRACT:
An acid-labile protein is described that, when incubated with the 53-Kd acid-stable protein occupied by IGF, converts it to a high molecular weight complex, corresponding to the in vivo form of IGF. This protein is called the acid-labile subunit (ALS) of IGF binding protein complex and is provided in biologically pure form. ALS is useful in treating wounds and promoting cellular growth. The nucleic acid encoding ALS, antibodies binding thereto, and fragments thereof are also disclosed.
REFERENCES:
Baxter & Cowell, "Diurnal Rhythm of Growth Hormone-Independent Binding Protein for Insulin-Like Growth Factors in Human Plasma" J. Clin. & Metab. 65(3) :432-440 (1987).
Baxter & Martin, "Binding Proteins for Insulin-Like Growth Factors in Adult Rat Serum. Camparsion With Other Human Rat Binding Proteins" Biochem.& Biophys. Res. Comm. 147 (1) :408-415 (1987).
Baxter & Martin, "Radioimmunoassay of Growth Horomone-dependent Insulinlike Growth Factor Binding Protein in Human Plasma" J. Clin. Invest. 78:1504-1512 (1986).
Baxter et al., "Growth Hormone-Dependent Insulin-Like Growth Factor (IGF) Binding Protein from Human Plasma Differs from Other Human IGF Binding Proteins" Biochem. Biophys. Res. Comm. 139 (3) :1256-1261 (1986).
Baxter et al., "High Moleculer Weight Insulin-like Growth Factor Binding Protein Complex" Journal of Biological Chemistry 264(20) :11843-11848 (1989).
Baxter, Robert C., "Characterization of the Acid-Labile Subunit of the Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein Complex" J. Clin. Endo.& Metab. 67 (2) :265-272 (1988).
Baxter, Robert C., "Circulating Levels and Molecular Distribution of the Acid-Labile (.alpha.) Subunit of the High Molecular Weight Insulin-Like Growth Factor-Binding Protein Complex" J. Clin Endo. & Metab. 70(5) :1347-1353 (1990).
Baxter, Robert C., "The Insulin-Like Growth Factors and Their Binding Proteins" Comp. Biochem. Physiol. 91B(2) :229-235 (1988).
Brewer et al., "Cloning, Characterization, and Expression of a Human Insulin-Like Growth Factor Binding Protein" Biochem.& Biophys. Res. Comm. 152(3) :1289-1297 (1988).
Cinningham et al., "The Complete Amino Sequence of .beta..delta.02-Microglobulin" Biochemistry 12 (24) :4811-4821 (1973).
Czech & Massague, "Subunit and dynamics of the insulin receptor" Fed. Proc. 41(11) :2719-2723 (1982).
Daughaday et al., "Characterization of Somatomedian Binding in Human Serum by Ultracentrifugation and Gel Filtration" J. Clin. Endo. & Metab. 55(5) :916-921 (1982).
Furlanetto & Van Wyk, "Studies on the Somatomedin-C-Binding Protein Evidence for a Heterlogous Subunit Structure" Proceedings-Endocrine Soc., 60th Annual Meeting (abstract 412) Jun. 1978).
Furlanetto, Richard W., "The Somatomedin C Binding Protein: Evidence for a Heterolgous Subunit Structure" J. Clin. Endo.& Metab. 51(1) :12-19 (1980).
Guler et al., "Insulin-like growth factors I and II in healthy man. Estimates of half-lives and production rates" Acta Endocrinologica (Copenhagen) 121:753-758 (1989).
Hintz and Liu, "Somatomedin Plasma Binding Proteins" Growth Hormone and other Biologically Active Peptides, Pecile and Muller, Amsterdam:Excerpta Medica pp. 133-143 (1980).
Hintz et al., "Demonstration of Specific Plasma Protein Binding Sites for Somatomedin" J. Clin. Endo. & Metab. 45(5) :988-995 (1997).
Lee et al., "Insulin-Like Growth Factor (IGF) Binding Protein Complementary Deoxyribonucleic Acid from Human HEP G2 Hepatoma Cells: Predicted Protein Sequence Suggests an IGF Binding Domain Different from Those of the IGF-I and IGF-II Receptors" Mol. Endocrinol. 2(5) :404-411 (1988).
Martin & Baxter, "Antibody Against Acid-Stable Insulin-Like Growth Factor Binding Protein Detects 150,000 Mol. Wt Growth Hormone-Dependent Complex in Human Plasma" J. Clin. Endo.& Metab. 61(4) :799-801 (1985).
Martin & Baxter, "Insulin-Like Growth Factor-binding Protein from Human Plasma" Journal of Biological Chemistry 261(19) :8754-8760 (1986).
Massague & Czech, "The Subunit Structures of Two Distinct Receptors for Insulin-like Growth Factors I and II and Their Relationship to the Insulin Receptor" Journal of Biological Chemistry 257(9) :5038-5045 (1982).
Moses et al., "Futher Characterization of Growth Hormone-Dependent Somatomedin-Binding Proteins in Rat Serum and Demonstration of Somatomedin-Binding Proteins Produced by Rat Liver Cells" Endocrinology 104(2) :536-546 (1979).
Pilch et al., "The Ligand Binding Subunit of the Insulin-Like Growth Factor 1 Receptor has Properties of a Peripheral Membrane Protein" Biochem. & Biophys. Res. Comm. 136(1) :45-50 (1986).
White et al., "The Growth Hormone Dependence of a Somatomedin-Binding Protein in Human Serum" J. Clin. Endo. & Metab. 53(1) :49-57 (1981).
Wilkins & D'Ercole, "Affinity-labeled Plasma Somatomedin-C/Insulinlike Growth Factor I Binding Proteins" J. Clin. Invest. 75:1350-1358 (1989).
Brown Karen E.
Dreger, Esq. Walter H.
Genetech, Inc.
Uem John
LandOfFree
Acid-labile subunit als of insulin-like growth factor binding pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acid-labile subunit als of insulin-like growth factor binding pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acid-labile subunit als of insulin-like growth factor binding pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1457858